New evidence for the diastolic J‐curve effect challenges the safety of intensive blood pressure control

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Journal of Clinical Hypertension

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jch.12962PMID 28042913PMCID PMC8031231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New evidence for the diastolic J‐curve effect challenges the safety of intensive blood pressure control

  2017cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2017cited by this paper
• Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

  2016cited by this paper
• Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

  2016cited by this paper
• Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? Position Statement of the Latin American Society of Hypertension

  2016cited by this paper
• Hypertension and stroke: an appraisal of the evidence and implications for clinical management

  2016cited by this paper
• Troponin and the J-Curve of Diastolic Blood Pressure: When Lower Is Not Better.

  2016cited by this paper
• [A randomized trial of intensive versus standard blood pressure control].

  2016cited by this paper
• The impact of SPRINT on the future treatment of hypertension: a mini review.

  2016cited by this paper
• Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.

  2016cited by this paper
• 60 A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalisation and enrollment in a disease management program

  2016cited by this paper
• Generalizability of SPRINT Results to the U.S. Adult Population.

  2016cited by this paper
• Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

  2016cited by this paper
• Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

  2016cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2016cited by this paper
• Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population

  2015cited by this paper
• Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

  2015cited by this paper
• Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population.

  2014cited by this paper
• Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.

  2013cited by this paper
• High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

  2013cited by this paper
• Blood Pressure J-Curve: Current Concepts

  2012cited by this paper
• Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

  2011cited by this paper
• Current status of aggressive blood glucose and blood pressure control in diabetic hypertensive subjects.

  2011cited by this paper
• Current status of aggressive blood pressure control.

  2011cited by this paper
• Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events.

  2010cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.

  2010cited by this paper
• Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

  2010cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention

  2007cited by this paper
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

  2007cited by this paper
• Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

  2006cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Upward Shift of the Lower Range of Coronary Flow Autoregulation in Hypertensive Patients With Hypertrophy of the Left Ventricle

  1991cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper
• Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure.

  1988cited by this paper
• Diastolic Coronary Artery Pressure‐Flow Relations in the Dog

  1978cited by this paper

• Relationship Between Subclinical Renal Damage and Maximum Rate of Blood Pressure Variation Assessed by Fourier Analysis of 24-h Blood Pressure Curve in Patients with Essential Hypertension

  2025cites this paper
• Sex Differences in Achieved Diastolic Blood Pressure and Cardiovascular Outcomes in Elderly Patients With Hypertension

  2025cites this paper
• The debate over the optimal blood pressure treatment target of less than 130/80 mmHg

  2022influential citation
• The J-Curve Association Between Blood Pressure and Mortality in Stroke Survivors

  2021cites this paper
• The clinical significance of isolated diastolic hypertension

  2020cites this paper
• A koszorúér-betegség előfordulása kezelt hipertóniában a vérnyomásértékek függvényében. Magyar Hipertónia Regiszter 2011–2013–2015

  2020cites this paper
• Orthostatic hypotension and cardiovascular outcomes: Should we be concerned?

  2020cites this paper
• Benefits and pitfalls of sacubitril/valsartan treatment in patients with hypertension

  2018cites this paper
• Aggressive systolic blood pressure control in older subjects: benefits and risks

  2018cites this paper
• Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.

  2017cites this paper
• New evidence for the diastolic J‐curve effect challenges the safety of intensive blood pressure control

  2017cites this paper